Agenda
The schedule presented here is subject to change as the agenda is finalized.
HIV and Cognitive Decline: Understanding HIV-Associated Neurocognitive Disorder
With advancements in HIV treatment, individuals living with HIV are now living longer, By 2030, 70% of people living with HIV (PLWH) will be ages 50 and older. But, as PLWH age they face unique challenges, particularly with cognitive health. One major concern is HIV-Associated Neurocognitive Disorder (HAND), a form of cognitive decline more common among PLWH. This presentation will provide a brief overview of HIV care; the signs and risk factors for HAND; similarities and differences between HAND and Alzheimer’s disease; and why accurately diagnosing cognitive change in PLWH is so important.
Similar Sessions
Commercial Support Acknowledgement
This conference is supported, in part, by independent educational grants from ineligible companies. A full list of supporters is available here. All accredited content has been developed and delivered in accordance with the ACCME Standards for Integrity and Independence and the criteria of Joint Accreditation for Interprofessional Continuing Education™, and is free of commercial bias.